Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brad Hively currently holds 683,721 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brad Hively has been a net seller of TOI stock. They have purchased $0 and sold $326.5K worth of shares.
Brad Hively's most recent insider trade was on Dec 15, 2025, when they sold 13,333 shares at $3.77 per share.
Brad Hively serves as Executive at Oncology Institute, Inc. (TOI). They have executed 22 insider transactions totaling $326.5K over their tenure at the company.
Brad Hively holds the position of Executive at Oncology Institute, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Brad Hively has shown a selling trading pattern, with $0 in total purchases and $326.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brad Hively was on Nov 13, 2023, when they sold $118.4K worth of TOI shares. This transaction involved 47,000 shares at $2.52 per share.
Brad Hively currently owns 683,721 shares of Oncology Institute, Inc. (TOI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brad Hively's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brad Hively has 22 Form 4 filings on record as an insider at Oncology Institute, Inc..
Set alerts for Brad Hively and 40,000+ other insiders.